News
CGM-AST remains the leader in Tamper-evident security products. Laser technology enables greater flexibility in assuring product authentication, while enhancing tamper evidence.
A new continuous glucose monitor (CGM) that is not only non-invasive but that predicts blood sugar levels from ECG data promises to shake up diabetes management. The device is being showcased at ...
Shipping giant CMA CGM and tech startup Mistral AI expect rapid productivity gains from a 100 million euro partnership unveiled on Sunday, which the French firms also touted as a commitment to ...
CMA CGM is reshuffling its deck of vessels to expand its presence in the Red Sea. Starting in June, the ocean carrier will reroute its Med Express (MEDEX) service-which connects ports across the ...
Shipping giant CMA CGM's air cargo branch will take delivery of two Boeing 777 Freighters later this year as it opens a new trans-Pacific route and has ordered a fifth one for next year, it said ...
French shipping operator CMA CGM is seeking to buy Swiss-based Ceva Logistics in a move to add revenue streams from freight logistics to its core ocean transportation business.
Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with continuous glucose monitoring, regardless of treatment regimen.
Meet the decade's best-performing U.S. diversified stock mutual fund: Ken Heebner's $3.7 billion CGM Focus Fund, which rose more than 18% annually and outpaced its closest rival by more than three ...
CMA CGM expects its profit to ease further for the rest of the year after a first-quarter decline, as an uncertain economy and influx of new vessels cool the container shipping market after a ...
Signos launches a 20,000 person study on the effects of combining a real-time CGM with a health app to improve health outcomes and weight management.
Apollon, a startup company in Seoul, Korea, developing wearable medical devices based on Raman spectroscopy, has agreed a collaboration with the Massachusetts Institute of Technology (MIT) aimed at ...
Apollon, a medtech startup, will collaborate with the LBRC at MIT with the aim of developing and conducting clinical trials of non-invasive CGMs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results